- Previous Close
13.74 - Open
13.64 - Bid 13.29 x --
- Ask 13.30 x --
- Day's Range
13.13 - 13.70 - 52 Week Range
9.99 - 15.41 - Volume
4,946,134 - Avg. Volume
5,475,356 - Market Cap (intraday)
2.907B - Beta (5Y Monthly) 0.37
- PE Ratio (TTM)
166.25 - EPS (TTM)
0.08 - Earnings Date --
- Forward Dividend & Yield 0.02 (0.15%)
- Ex-Dividend Date Jul 15, 2024
- 1y Target Est
--
Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. The company's products portfolio includes valsartan, losartan, clopidogrel, perindopril, rosuvastatin calcium, atorvastatin calcium, purin bahrain, and other products. It offers APIs, intermediates, and preparations for the treatment of cardiovascular, central nervous system, gastrointestinal tract, and other therapeutic areas. Ningbo Menovo Pharmaceutical Co., Ltd. was founded in 2004 and is headquartered in Ningbo, China.
www.menovopharm.com2,353
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 603538.SS
View MorePerformance Overview: 603538.SS
Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 603538.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 603538.SS
View MoreValuation Measures
Market Cap
3.00B
Enterprise Value
3.63B
Trailing P/E
171.75
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.64
Price/Book (mrq)
1.38
Enterprise Value/Revenue
2.94
Enterprise Value/EBITDA
57.64
Financial Highlights
Profitability and Income Statement
Profit Margin
1.64%
Return on Assets (ttm)
0.55%
Return on Equity (ttm)
1.07%
Revenue (ttm)
1.24B
Net Income Avi to Common (ttm)
20.3M
Diluted EPS (ttm)
0.08
Balance Sheet and Cash Flow
Total Cash (mrq)
785.91M
Total Debt/Equity (mrq)
62.46%
Levered Free Cash Flow (ttm)
-48.07M